C.R. Bard Inc. announced in late September that it has entered into a definitive agreement to acquire Kobayashi Pharmaceutical’s 50 percent ownership share in Medicon Inc., the Osaka, Japan-based joint venture of the two companies, through a share redemption.

November 3, 2015 — Pulmonary embolism (PE) is a potentially life-threatening condition that occurs, for example, when a ...

In recognition of World Stroke Day, the patient-focused organization StopAfib.org launched a diverse set of materials for engaging and empowering people living with atrial fibrillation (AF). The materials are intended to increase the ability of patients to be engaged in their own treatment and stroke prevention decisions.

Miracor Medical Systems GmbH announced that its PiCSO system was highlighted during the 2015 Transcatheter Cardiovascular Therapeutics (TCT) conference in San as offering new hope for cardioprotection during percutaneous coronary intervention (PCI).

Boston Scientific Corp. has received CE Mark on magnetic resonance imaging (MRI) conditional labeling for the current family of EL (Extended Longevity) and Mini implantable cardioverter defibrillator (ICD) and the X4 cardiac resynchronization therapy defibrillator (CRT-D) systems. This revised labeling ensures that future patients and those already implanted with these systems are able to undergo MRI scans if indicated.